Epidemiology and Pathogenesis of Esophageal Cancer

Blot, 1999, The changing epidemiology of esophageal cancer, Semin Oncol, 26, 2 Brown, 2002, Epidemiologic trends in esophageal and gastric cancer in the United States, Surg Oncol Clin N Am, 11, 235, 10.1016/S1055-3207(02)00002-9 Crew, 2004, Epidemiology of upper gastrointestinal malignancies, Semin Oncol, 31, 450, 10.1053/j.seminoncol.2004.04.021 Lagergren, 2005, Adenocarcinoma of oesophagus: What exactly is the size of the problem and who is at risk?, Gut, 54, 1, 10.1136/gut.2004.041517 Pera, 2005, Epidemiology of esophageal adenocarcinoma, J Surg Oncol, 92, 151, 10.1002/jso.20357 Shaheen, 2002, Gastroesophageal reflux, barrett esophagus, and esophageal cancer: Scientific review, JAMA, 287, 1972, 10.1001/jama.287.15.1972 Parkin, 1998 Gammon, 1997, Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia, J Natl Cancer Inst, 89, 1277, 10.1093/jnci/89.17.1277 Garavello, 2005, Family history of cancer, its combination with smoking and drinking, and risk of squamous cell carcinoma of the esophagus, Cancer Epidemiol Biomarkers Prev, 14, 1390, 10.1158/1055-9965.EPI-04-0911 Lindblad, 2005, Body mass, tobacco and alcohol and risk of esophageal, gastric cardia, and gastric non-cardia adenocarcinoma among men and women in a nested case-control study, Cancer Causes Control, 16, 285, 10.1007/s10552-004-3485-7 Lee, 2005, Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan, Int J Cancer, 113, 475, 10.1002/ijc.20619 Tran, 2005, Prospective study of risk factors for esophageal and gastric cancers in the Linxian general population trial cohort in China, Int J Cancer, 113, 456, 10.1002/ijc.20616 Farrow, 2000, Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer, Cancer Causes Control, 11, 231, 10.1023/A:1008913828105 Chow, 1995, The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia, JAMA, 274, 474, 10.1001/jama.274.6.474 Chow, 1998, Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia, J Natl Cancer Inst, 90, 150, 10.1093/jnci/90.2.150 Ji, 1997, Body mass index and the risk of cancers of the gastric cardia and distal stomach in Shanghai, China, Cancer Epidemiol Biomarkers Prev, 6, 481 Lagergren, 1999, Association between body mass and adenocarcinoma of the esophagus and gastric cardia, Ann Intern Med, 130, 883, 10.7326/0003-4819-130-11-199906010-00003 Wu, 2001, A multiethnic population-based study of smoking, alcohol and body size and risk of adenocarcinomas of the stomach and esophagus (United States), Cancer Causes Control, 12, 721, 10.1023/A:1011290704728 Vaughan, 2002, Nonsteroidal anti-inflammatory drug use, body mass index, and anthropometry in relation to genetic and flow cytometric abnormalities in Barrett’s esophagus, Cancer Epidemiol Biomarkers Prev, 11, 745 Mayne, 2001, Nutrient intake and risk of subtypes of esophageal and gastric cancer, Cancer Epidemiol Biomarkers Prev, 10, 1055 Navarro, 2004, Dietary and lifestyle patterns and risk of subtypes of esophagel and gastric cancer: factor analysis, J Nutr, 134, 3521S De Stefani, 2005, The role of vegetable and fruit consumption in the aetiology of squamous cell carcinoma of the oesophagus: A case-control study in Uruguay, Int J Cancer, 116, 130, 10.1002/ijc.20950 Gonzalez, 2006, Meat intake and risk of stomach and esophageal adenocarcinoma within the European Prospective Investigation Into Cancer and Nutrition (EPIC), J Natl Cancer Inst, 98, 345, 10.1093/jnci/djj071 Jansson, 2005, Socioeconomic factors and risk of esophageal adenocarcinoma: A nationwide Swedish case-control study, Cancer Epidemiol Biomarkers Prev, 14, 1754, 10.1158/1055-9965.EPI-05-0140 Farrow, 1998, Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer, Cancer Epidemiol Biomarkers Prev, 7, 97 Corley, 2003, Protective association of aspirin/NSAIDs and esophageal cancer: A systematic review and meta-analysis, Gastroenterology, 124, 47, 10.1053/gast.2003.50008 Vaughan, 2005, Non-steroidal anti-inflammatory drugs and risk of neoplastic progression in Barrett’s oesophagus: A prospective study, Lancet Oncol, 6, 945, 10.1016/S1470-2045(05)70431-9 Vaughan, 1998, Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux, Cancer Epidemiol Biomarkers Prev, 7, 749 Corley, 2006, Barrett’s esophagus and medications that relax the lower esophageal sphincter, Am J Gastroenterol, 101, 937, 10.1111/j.1572-0241.2006.00539.x Lagergren, 2000, Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma, Ann Intern Med, 133, 165, 10.7326/0003-4819-133-3-200008010-00007 Peek, 2006, Helicobacter infection and gastric neoplasia, J Pathol, 208, 233, 10.1002/path.1868 Ye, 2004, Helicobacter pylori infection and gastric atrophy: Risk of adenocarcinoma and squamous-cell carcinoma of the esophagus and adenocarcinoma of the gastric cardia, J Natl Cancer Inst, 96, 388, 10.1093/jnci/djh057 Jansson, 2006, Airborne occupational exposures and risk of oesophageal and cardia adenocarcinoma, Occup Environ Med, 63, 107, 10.1136/oem.2005.022467 Engel, 2002, Occupation and risk of esophageal and gastric cardia adenocarcinoma, Am J Ind Med, 42, 11, 10.1002/ajim.10077 Lindblad, 2006, Hormone replacement therapy and risks of oesophageal and gastric adenocarcinomas, Br J Cancer, 94, 136, 10.1038/sj.bjc.6602906 Zheng, 1993, Declining incidence is greater for esophageal than gastric cancer in Shanghai, People’s Republic of China, Br J Cancer, 68, 978, 10.1038/bjc.1993.465 Sampliner, 2002, Updated guidelines for the diagnosis, surveillance, and therapy of Barrett’s esophagus, Am J Gastroenterol, 97, 1888, 10.1111/j.1572-0241.2002.05910.x Provenzale, 1999, Barrett’s esophagus: A new look at surveillance based on emerging estimates of cancer risk, Am J Gastroenterol, 94, 2043, 10.1111/j.1572-0241.1999.01276.x